A history of harmful substance use or dependence is common among people in Criminal Justice Systems (CJSs) around the world. The time after an individual has left the CJS is of elevated risk for those with harmful substance use - with high rates of relapse, accidental overdose and suicide. Despite this, there is often poor access to treatments while incarcerated or on release from the CJS. This webinar will look at a PRISMA-compliant systematic review that was conducted to explore the evidence for extended-release substance use pharmacotherapy for incarcerated or recently released participants (less than 3 months).
About the speaker
Amelia is 2nd year PhD Candidate and Medical Doctor based at Drug and Alcohol Services - SA Health (DASSA) in South Australia. She completed a Masters of Addictive Behaviours (Monash University/Turning Point) in 2018 and has since held roles conducting research and supporting medical registrars in conducting research. In her clinical roles, she has worked as a GP in the Aboriginal and Prison Health Services and continues to work and research at the intersection of delivering Addiction Medicine, particularly for Aboriginal and incarcerated clients.